| 000 | 01684 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517135054.0 | ||
| 264 | 0 | _c20170808 | |
| 008 | 201708s 0 0 eng d | ||
| 022 | _a1528-0012 | ||
| 024 | 7 |
_a10.1053/j.gastro.2017.01.017 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGane, Edward J | |
| 245 | 0 | 0 |
_aEfficacy of Ledipasvir Plus Sofosbuvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2 Infection. _h[electronic resource] |
| 260 |
_bGastroenterology _c05 2017 |
||
| 300 |
_a1366-1371 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBenzimidazoles _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 |
_aFatigue _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorenes _xadministration & dosage |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHeadache _xchemically induced |
| 650 | 0 | 4 |
_aHepacivirus _xgenetics |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNausea _xchemically induced |
| 650 | 0 | 4 |
_aSofosbuvir _xadministration & dosage |
| 650 | 0 | 4 | _aSustained Virologic Response |
| 700 | 1 | _aHyland, Robert H | |
| 700 | 1 | _aYang, Yin | |
| 700 | 1 | _aSvarovskaia, Evguenia | |
| 700 | 1 | _aStamm, Luisa M | |
| 700 | 1 | _aBrainard, Diana M | |
| 700 | 1 | _aMcHutchison, John G | |
| 700 | 1 | _aStedman, Catherine A M | |
| 773 | 0 |
_tGastroenterology _gvol. 152 _gno. 6 _gp. 1366-1371 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1053/j.gastro.2017.01.017 _zAvailable from publisher's website |
| 999 |
_c26831739 _d26831739 |
||